Marine Membrane Lipid Extract(s)
Autoimmune Disorders
Pre-clinicalResearch & Development
Key Facts
About Arctic Bioscience
Arctic Bioscience leverages over 30 years of expertise in marine extracts to develop novel ingredients from herring roe, targeting the nutraceutical and pharmaceutical markets. Its mission is centered on providing effective and healthy therapies for people with autoimmune disorders using its proprietary marine membrane lipid technology. The company has established the 'Romega' brand for its nutraceutical products and maintains a strong commitment to sustainability and scientific validation. While currently private and likely pre-revenue from its pharmaceutical pipeline, it represents a specialized player in the marine bioactives space.
View full company profileTherapeutic Areas
Other Autoimmune Disorders Drugs
| Drug | Company | Phase |
|---|---|---|
| Humira | Royalty Pharma | Commercial |
| Immunomodulation Programs | Fosun Pharma | Various Phases |
| Adalimumab Biosimilar | Glenmark Pharmaceuticals | Phase 3 |
| Autoimmune Disease Programs | TScan Therapeutics | Discovery |
| Autoimmune Diagnostics (Immco) | Trinity Biotech | Approved/Commercial |
| TYK2 Pseudokinase Inhibitor | A2A Pharma | Preclinical |